Seminars in Radiation Oncology
Volume 20, Issue 2 , Pages 107-115, April 2010

Adaptive Management of Liver Cancer Radiotherapy

  • Kristy K. Brock, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Kristy K. Brock, PhD, Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, 610 University Avenue, Rm 7–502B, Toronto, ON, Canada M5G 2M9
  • ,
  • Laura A. Dawson, MD

Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, ON, Canada

Adaptive radiation therapy for liver cancer has the potential to reduce normal tissue complications and enable dose escalation, allowing the potential for tumor control in this challenging site. Using adaptive techniques to tailor treatment margins to reflect patient-specific breathing motions and image-guidance techniques can reduce the high dose delivered to surrounding normal tissues while ensuring that the prescription dose is delivered to the tumor. Several treatment planning and delivery techniques have been developed for use in the liver, including a margin to encompass the full breathing motion, mean position techniques, which evaluate the probability of tumor location during breathing, breath hold, gating, and tracking. Patient selection, clinical workflow, and quality assurance must be considered and developed before integrating these techniques into clinical practice.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr Brock is supported by a research chair from Cancer Care Ontario. Her research is supported in part by NIH 1R01CA124714-01A2 and National Cancer Institute of Canada-Terry Fox Foundation. She also receives funding from Elekta Oncology Systems, Philips Medical Systems, and RaySearch Laboratories and serves on the IMPAC Physics Advisory Board.

 Dr Dawson's research is supported in part by National Cancer Institute of Canada (NCIC #18207), The Canadian Cancer Society, Canadian Institutes for Health Research (#02477), and Elekta Oncology Systems.

PII: S1053-4296(09)00078-2

doi:10.1016/j.semradonc.2009.11.004

Seminars in Radiation Oncology
Volume 20, Issue 2 , Pages 107-115, April 2010